Browsing by author "Campo, Elías"

Repository

How to publish

Resources

FAQs

Now showing items 1-16 of 16

Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions

Suárez Puente, Xosé Antón; Jares, Pedro; Campo, Elías (2018)
Discovery of clinically distinct CLL subgroups by integrative mapping of large-scale genetic, epigenetic, expression and clinical data

Knisbacher, Binyamin A.; Lin, Ziao; Stewart, Chip; Hahn, Cynthia K.; Stevenson, Kristen E.; Neuberg, Donna S.; Martin Subero, José, I.; Suárez Puente, Xosé Antón; Campo, Elías; Wu, Catherine J.; Getz, Gad (2020)
Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia

Ramsay, Andrew John; Rodríguez Martínez, David; Villamor Casas, Neus; Kwarciak, Agnieszka; Tejedor Vaquero, Juan Ramón; Valcárcel, Juan; López Guillermo, Armando; Martínez Trillos, Alejandra; Suárez Puente, Xosé Antón; Campo, Elías; López Otín, Carlos; Quesada Fernández, Víctor (2013)
Functional analysis of sucrase-isomaltase mutations from chronic lymphocytic leukemia patients

Rodríguez Martínez, David; Ramsay, Andrew John; Quesada Fernández, Víctor; Garabaya Fernández, Cecilia; Campo, Elías; Pérez Freije, José María; López Otín, Carlos (2013)
Genetic and epigenetic basis of chronic lymphocytic leukemia

Martín Subero, J. I.; López Otín, Carlos; Campo, Elías (2013)
The genomic landscape of chronic lymphocytic leukemia: clinical implications

Quesada Fernández, Víctor; Ramsay, Andrew John; Rodríguez Martínez, David; Suárez Puente, Xosé Antón; Campo, Elías; López Otín, Carlos (2013)
Human cathepsin L2 protein, gene encoding said protein and use thereof

Santamaría Ruiz de Azúa, Íñigo; Velasco Cotarelo, María Gloria; Cazorla, Maite; Fueyo Silva, Antonio Manuel; Campo, Elías; López Otín, Carlos (2004-10-05)
Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells

Arimany-Nardi, C.; Montraveta, Arnau; Lee-Verges, E.; Suárez Puente, Xosé Antón; Koepsell, H.; Campo, Elías; Colomer, D.; Pastor-Anglada, M. (2015)
Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens

Delgado, J.; Bielig, T.; Bonet, Lizette; Carnero-Montoro, Elena; Suárez Puente, Xosé Antón; Colomer, D.; Bosch, Elena; Campo, Elías; Lozano, Francisco (2017)
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics

Speedy, H. E.; Beekman, R.; Chapaprieta, V.; Orlando, G.; Law, P. J.; Martín García, D.; Gutiérrez Abril, Jesús; Catovsky, D.; Beà, S.; Clot, G.; Puiggròs, M.; Torrents, D.; Suárez Puente, Xosé Antón; Allan, J. M.; López Otín, Carlos; Campo, Elías; Houlston, R. S.; Martín Subero, J. I. (2019)
Molecular pathogenesis of CLL and its evolution

Rodríguez Martínez, David; Bretones Sánchez, Gabriel; Rodríguez Arango, Javier; Valdespino, Víctor; Campo, Elías; Quesada Fernández, Víctor; López Otín, Carlos (2015)
Next-Generation Sequencing in Chronic Lymphocytic Leukemia

Villamor Casas, Neus; López Guillermo, Armando; López Otín, Carlos; Campo, Elías (2013)
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

Ramsay, Andrew John; Quesada Fernández, Víctor; Foronda, Miguel; Conde del Campo, Laura; Martínez Trillos, Alejandra; Villamor Casas, Neus; Rodríguez Martínez, David; Kwarciak, Agnieszka; Garabaya Fernández, Cecilia; Gallardo, Mercedes; López Guerra, Mónica; López Guillermo, Armando; Suárez Puente, Xosé Antón; Blasco Marhuenda, María Antonia; Campo, Elías; López Otín, Carlos (2013)
Recurrent gene mutations in CLL

Martínez-Trillos, Alejandra; Quesada Fernández, Víctor; Villamor Casas, Neus; Suárez Puente, Xosé Antón; López Otín, Carlos; Campo, Elías (Springer, 2013)
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

Xargay-Torrent, Sçilvia; López Guerra, Mónica; Rosich, Laia; Montraveta, Arnau; Roldán, Jocabed; Rodríguez, Vanina; Villamor Casas, Neus; Aymerich, Marta; Lagisetti, Chandraiah; Webb, Thomas R.; López Otín, Carlos; Campo, Elías; Colomer, Dolors (2015)
Timing the initiation of multiple myeloma

Maura, Francesco; Rustad, Even; Yellapantula, Venkata; Bolli, Niccolo; Leongamornlert, Daniel; Nadeu, Ferran; Angelopoulos, Nicos; Dawson, Kevin; Mitchell, Thomas; Osborne, Rob; Ziccheddu, Bachisio Ziccheddu; Carniti, Cristiana; Montefusco, Vittorio; Corradini, Paolo; Anderson, Kenneth C.; Moreau, Philippe; Papaemmanuil, Elli; Alexandrov, Ludmil; Suárez Puente, Xosé Antón; Campo, Elías; Siebert, Reiner; Avet-Loiseau, Herve; Munshi, Nikhil; Campbell, Peter; Landgren, C. Ola (2019)

Browsing by author "Campo, Elías"

Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions ﻿

Discovery of clinically distinct CLL subgroups by integrative mapping of large-scale genetic, epigenetic, expression and clinical data ﻿

Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia ﻿

Functional analysis of sucrase-isomaltase mutations from chronic lymphocytic leukemia patients ﻿

Genetic and epigenetic basis of chronic lymphocytic leukemia ﻿

The genomic landscape of chronic lymphocytic leukemia: clinical implications ﻿

Human cathepsin L2 protein, gene encoding said protein and use thereof ﻿

Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells ﻿

Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens ﻿

Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics ﻿

Molecular pathogenesis of CLL and its evolution ﻿

Next-Generation Sequencing in Chronic Lymphocytic Leukemia ﻿

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia ﻿

Recurrent gene mutations in CLL ﻿

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia ﻿

Timing the initiation of multiple myeloma ﻿

Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions

Discovery of clinically distinct CLL subgroups by integrative mapping of large-scale genetic, epigenetic, expression and clinical data

Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia

Functional analysis of sucrase-isomaltase mutations from chronic lymphocytic leukemia patients

Genetic and epigenetic basis of chronic lymphocytic leukemia

The genomic landscape of chronic lymphocytic leukemia: clinical implications

Human cathepsin L2 protein, gene encoding said protein and use thereof

Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells

Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens

Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics

Molecular pathogenesis of CLL and its evolution

Next-Generation Sequencing in Chronic Lymphocytic Leukemia

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

Recurrent gene mutations in CLL

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

Timing the initiation of multiple myeloma